See All Slides - tctmd.com

Slides

Presentation TCT 2016

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis

November 01, 2016

Presentation TCT 2016

How to Perform Transseptal Puncture Safely and Effectively

Presenter: Maurice Buchbinder, Saibal Kar, Stefan C. Bertog

November 01, 2016

Presentation TCT 2016

Interatrial Shunts in HFpEF: Focus on Corvia

Presenter: Josep Rodés-Cabau, Nir Uriel, Sanjiv Shah

November 01, 2016

Presentation TCT 2016

Pulmonary Artery Denervation for Pulmonary Hypertension II: Catheter Development, Procedure, and Acute and Late Hemodynamic Results

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Shao-Liang Chen

November 01, 2016

Presentation TCT 2016

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Presenter: Sriram S. Iyer, John R. Laird Jr., William A. Gray

November 01, 2016

Presentation TCT 2016

FFR in ACS: Specifics and Timing of Measurements

Presenter: Nick Curzen, Nils Johnson, Habib Samady

November 01, 2016

Presentation TCT 2016

TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis.

Presenter: Alan C. Yeung, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

Presentation TCT 2016

TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR

Presenter: Eric Boersma, James E. Muller

November 01, 2016

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Advertisement

Slides

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

How to Perform Transseptal Puncture Safely and Effectively

Interatrial Shunts in HFpEF: Focus on Corvia

Pulmonary Artery Denervation for Pulmonary Hypertension II: Catheter Development, Procedure, and Acute and Late Hemodynamic Results

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

FFR in ACS: Specifics and Timing of Measurements

TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis.

TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry

TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content